Bicara Therapeutics Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BCAX | BINV.ST | AVBP | CBIO | OBX | IDYA | |
|---|---|---|---|---|---|---|
| Market cap | 588.28M | 246.77M | 665.16M | 513.37M | 678.88M | 3.12B |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -2.6 | -1.0 | -3.6 | -5.3 | -5.2 | -7.9 |
| Price/book | 1.3 | 1.2 | 1.8 | 2.9 | -0.8 | 2.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −36.63% | −88.73% | −26.64% | +5.07% | −37.20% | +8.41% |
| Today | −0.78% | +4.60% | +3.61% | +5.82% | −16.93% | +3.29% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All BCAX news ›ACG Acquisition’s (ACG) Buy Rating Reiterated at Berenberg Bank
Posted by Mitch Edgeman on Nov 3rd, 2026 ACG Acquisition (LON:ACG – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Berenberg Bank in a research note issued on Tuesday, Digital Look reports. They presently have a…
Bicara Therapeutics (BCAX) Set to Announce Quarterly Earnings on Monday
Posted by Tristan Rich on Nov 2nd, 2026 Bicara Therapeutics (NASDAQ:BCAX – Get Free Report) last announced its quarterly earnings data on Tuesday, August 11th. The company reported ($0.82) earnings per share (EPS) for the quarter, meeting…
Agios Pharmaceuticals (NASDAQ:AGIO) Stock Rated Buy in New Coverage at HC Wainwright
Posted by Sarita Garza on Nov 1st, 2026 HC Wainwright began coverage on shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) in a research note released on Thursday, MarketBeat reports. The brokerage issued a buy rating and a $55.00…
Benitec Biopharma initiated with an Outperform at Raymond James
Raymond James analyst Tiago Fauth initiated coverage of Benitec Biopharma (BNTC) with an Outperform rating and $14 price target Benitec is a cl... Benitec Biopharma initiated with an Outperform at Raymond James Raymond James analyst Tiago…
BofA Upgrades Candel Therapeutics to Buy From Neutral, Price Target is $18
Candel Therapeutics has an average rating of buy and mean price target of $21.75, according to analysts polled by FactSet. ... Biotechnology & Medical Research BofA Upgrades Candel Therapeutics to Buy From Neutral, Price Target is $18…
Abivax (NASDAQ:ABVX) Stock Rating Reaffirmed as "Buy" by Guggenheim
Abivax (NASDAQ:ABVX - Get Free Report)'s stock had its "buy" rating reissued by stock analysts at Guggenheim in a report issued on Tuesday, Benzinga reports. They presently have a $175.00 price target on the stock. Guggenheim's price…
Bicara Therapeutics (NASDAQ:BCAX) Earns “Buy” Rating from BTIG Research
Bicara Therapeutics (NASDAQ:BCAX – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at BTIG Research in a research report issued on Monday, Benzinga reports. They presently have a $39.00 price objective on the…
ADENTRA Inc. (TSE:ADEN) Stock Now Rated "Buy" by Sell-Side Brokerages
Shares of ADENTRA Inc. (TSE:ADEN - Get Free Report) have been assigned a consensus recommendation of "Buy" from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. Seven investment analysts have rated the…
Bicara Therapeutics Inc. (NASDAQ:BCAX) Stock Rated “Moderate Buy” by Sell-Side Brokerages
View Our Latest Research Report on BCAX Shares of NASDAQ:BCAX opened at $16.56 on Wednesday. Bicara Therapeutics has a 12 month low of $13.70 and a 12 month high of $30.99. The company has a 50-day moving average price of $23.16 and a…
Bicara Therapeutics (NASDAQ:BCAX) Sees Unusually-High Trading Volume – What’s Next?
Posted by Sarita Garza on Oct 30th, 2026 Bicara Therapeutics Inc. (NASDAQ:BCAX – Get Free Report) saw unusually-high trading volume on Friday. Approximately 778,557 shares were traded during trading, an increase of 10% from the average…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- defenseworld.net5
- themarketsdaily.com5
- marketbeat.com2
- markets.businessinsider.com1
- marketscreener.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 14 articles, not a forecast.